SEC Form D private-offering filing

Canal Biosciences, Inc.

Name: Canal Biosciences, Inc. - new SEC Form D private-offering filing, Lowell, MA
Published: 2026-04-13

A new SEC Form D private-offering notice from Lowell, MA, a $3,249,996 filer-stated offering target in Biotech. The source filing is one click away.

Canal Biosciences, Inc. site↗ Verified via SEC Form D

Develops TrueLink, an NGS library preparation technology that attaches sequencing adaptors directly to native DNA ends without end repair, for liquid biopsy and precision medicine applications.

Filed 2026-04-13Filed to raise $3,249,996First money in 2026-03-18Raised so far $2,334,997HQ (as filed) Lowell, MASector Biotech ✓Stage (inferred) SeedCall status Delayed filing

Source linked the Form D on EDGAR↗Website verified canalbiosciences.com↗Named in the filing 3 executives & directors

Open this row on the live feed →More new filings in Massachusetts →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.